Jones Day advises clients across the full life sciences spectrum, boasting a particularly impressive litigation record before the Belgian courts and the CJEU. The firm’s esteemed clientbase consists of entities that are active in the digital health, pharmaceuticals, cosmetics and medical device sectors. The practice stands out for its transactional strength as well as its antitrust, tax and IP expertise. Cristiana Spontoni advises manufacturers, trade associations and research institutes on complex regulatory and compliance issues.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency
Testimonials
Collated independently by Legal 500 research team.
- ‘The team has been assisting us with a particularly challenging matter, and we have found them consistently accessible, responsive, and personable. They work extremely hard on each file, and the overall quality of their work is strong.'
Key clients
- AbbVie Inc.
- Accelmed Partners
- Amolyt Pharma SAS
- Ascensia Diabetes Care Holding AG
- Biocom California
- BioMarin Pharmaceutical Inc.
- Cibus, Inc
- GE Healthcare
- Grand Duchy of Luxembourg
- Institut Pasteur
- MedTech Europe
- Reneo Pharmaceuticals
Work highlights
Successfully represented AbbVie in the first Dutch human rights-based class action alleging excessive pricing of a patented medicine. The case highlights the firm’s ability to coordinate cross-border and cross-disciplinary teams across multiple practice groups and offices to address complex, high-profile pharmaceutical litigation.
Represents BioMarin in a wide array of regulatory, legal and litigation matters. These include assisting with: national pricing and reimbursement matters; the performance of clinical trials and post-market studies; sector-specific healthcare compliance and data privacy matters; M&A; IP; litigation; trade and tariffs; and other regulatory matters.
Successfully represented Biocom California in the landmark Illumina case (C-611/22) in which the European Court of Justice invalidated the European Commission's unlawful new Article 22 policy asserting jurisdiction over transactions falling below EU and national notification thresholds.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Cristiana Spontoni
Other key lawyers
Jörg Hladjk; Philipp Werner